
Our portfolio company, PostEra, AI for preclinical drug discovery, today announced a multi-target collaboration with Amgen. Their AI platform is set to advance up to 5 small molecule programs. PostEra has already closed $1B in AI partnerships.
prnewswire.com/news-releases/…
English





